Lakeland Industries, Inc. LAKE

FY2026 · ended Jan 31, 2026 · Revenue $192.60M, +15.2% YoY · Filed Apr 16, 2026

Lakeland Industries, Inc. (LAKE) files with the SEC under industry code 3842, Orthopedic, Prosthetic & Surgical Appliances & Supplies. In fiscal 2026, which ended Jan 31, 2026, it reported revenue of $192.6 million and a net loss of $25.3 million. Free cash flow was -$16.4 million. As of Jul 31, 2026 it held $17.9 million in cash and investments and $37.2 million in total debt.

Revenue
$192.60M
+15.2% vs prior year
Net income
$-25.31M
-40.0% vs prior year
Operating cash flow
$-15.75M
+0.8% vs prior year
Free cash flow
$-16.42M
+5.7% vs prior year
EPS
$-2.63
-8.2% vs prior year
Dividend per share
None
Shares outstanding
9.84M
+3.6% vs prior year
Net cash
$-19.29M
as of Jul 31, 2026
Operating margin
-8.1%
FY 2026

Company profile

Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
Listed as
LAKE (Nasdaq)
Fiscal year ends
January 31
Incorporated in
DE
Headquarters
Huntsville, AL
SEC filer status
Accelerated filer, Smaller reporting company
SEC CIK
798081
Former names
LAKELAND INDUSTRIES INC (until Sep 9, 2026)

Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2026
Jan 31, 2026
FY 2025
Jan 31, 2025
FY 2024
Jan 31, 2024
FY 2023
Jan 31, 2023
FY 2022
Jan 31, 2022
Revenue
$192.6M
$167.2M
$124.7M
—
$118.4M
Operating income
-$15.5M
-$9.3M
$6.0M
$5.5M
$16.0M
Net income
-$25.3M
-$18.1M
$5.4M
$1.9M
$11.4M
Diluted EPS
-$2.63
-$2.43
$0.72
$0.24
$1.41
Operating cash flow
-$15.8M
-$15.9M
$10.9M
-$5.5M
$12.8M
Free cash flow
-$16.4M
-$17.4M
$8.8M
-$7.4M
$12.0M
Total assets
$209.9M
$212.5M
$153.7M
$142.9M
$140.8M
Total liabilities
$80.8M
$65.9M
$30.3M
$22.9M
$15.7M
Stockholders' equity
$129.1M
$146.6M
$123.5M
$120.0M
$125.1M
Cash and investments
$12.5M
$17.5M
$27.4M
$24.6M
$52.7M
Total debt
$45.4M
$15.2M
$11.6M
$5.3M
$4.9M

Recent SEC filings

Recent SEC filings
Form Description Filed Period
10-Q Quarterly report Sep 9, 2026 Jul 31, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Sep 9, 2026 Sep 9, 2026
8-K Current report
Officer or director change, Shareholder vote results
Jun 18, 2026 Jun 18, 2026
10-Q Quarterly report Jun 9, 2026 Apr 30, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Jun 9, 2026 Jun 9, 2026
ARS Annual report to shareholders May 7, 2026 Jan 31, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.